- Elutia Q2 FY26 net loss narrows 20.4% to $7.6 million; net sales fall 11.7% to $2.4 million
- Ocular Therapeutix grants new SVP Beth Rada options for 85,000 shares, 28,000 RSUs under inducement plan
- Globant Q2 IFRS diluted EPS swings to USD 0.04; revenue flat at USD 614.4 million
- VolitionRx Q2 FY26 operating loss narrows 34% to $4.2 million; operating expenses fall 32% on year
- B-Gaming shareholder Tabanelli to launch voluntary offer to swap Boldt shares for B-Gaming stock
- Bleichroeder Acquisition II swings to Q2 net income of $298,688; H1 net loss widens to $2.39 million
- Howard Hughes director Mary Ann Tighe reports disposal of shares worth $907,063.92
- York Space Systems Q2 FY26 net loss widens 62% to $(39.34) million; revenue rises 10% to $92.55 million
- ServiceTitan President Vahe Kuzoyan disposes of USD 9.44 million in common shares
- Xylem files Form 3 initial beneficial ownership statement for director D. Christian Koch
- Lithium Americas raises $150 million via subordinated convertible debentures with YA II PN Ltd
- ONE Gas prices USD 375 million 5.45% senior notes due 2036 underwritten by BofA, RBC, Truist
- CPI Aerostructures returns to profit in Q2 FY26, net income $685,615; revenue rises 15.8% to $17.58 million
- Duke Energy prices USD 1.75 billion equity units backed by remarketable senior notes
- NYSE moves to delist SES AI warrants, halts trading immediately
- Birchtech publishes investor presentation on activated carbon technologies for mercury emissions and PFAS water treatment
- cbdMD FY26 Q3 operating loss widens to $1.13 million; net sales rise 20% to $5.6 million
- My Size FY26 Q2 net loss widens to $1.75 million; revenue rises to $3.07 million
- GrabAGun Q2 FY26 turns to net loss of $1.8 million; revenue rises 9.4% to $23.2 million
- Omeros appoints Tranceka Capital founder Joseph Schocken to board
- Matinas BioPharma FY26 Q2 net loss narrows to $3.25 million
- Xos Q2 FY26 operating loss widens to $7.9 million; revenue drops to $4.7 million
- XBP Global FY26 Q2 net loss narrows to USD 16.7 million; revenue drops 14% year-over-year to USD 191.3 million
- Nexentis Q2 FY26 net loss widens 154% to $11.16 million
- Unite Acquisition 1 net loss narrows 21% to $1.21 million in Q2 FY26
- Solarius Capital Acquisition swings to Q2 net income of $1.36 million; H1 net income rises to $2.75 million
- Oragenics Q2 net loss widens 11.3% to $2.53 million year over year
- Parker Hannifin draws USD 5.25 billion 364-day loan for Filtration Group deal
- Quantum BioPharma Q2 net loss narrows to USD 3.09 million; operating loss improves to USD 2.29 million
- Acurx net loss flat at $2.26 million in Q2 2026
- Soren Acquisition Q2 net income rises to $2.03 million
- Elite Pharmaceuticals Q1 FY27 operating income drops 65% to $7.5 million; revenue falls 20% to $32.4 million
- Illinois Tool Works prices $1.5 billion notes offering due 2029
- Yarrow Bioscience files amended 8-K report on merger exchange ratio update
- Aethlon Medical 1Q Loss/Shr $4.02 >AEMD
- Nektar Therapeutics 2Q Rev $10.1M >NKTR
- Nektar Therapeutics 2Q Loss/Shr $1.23 >NKTR
- Colombier Acquisition III Q2 net income rises to USD 2.42 million; six-month net income climbs to USD 2.78 million
- Affirm to join Goldman Sachs Communacopia + Technology Conference fireside chat
- Sunrise Realty Trust CFO Brandon Hetzel buys 713 common shares for $5,405.54
- Celcuity Q2 FY26 net loss widens to $78.9 million; operating expenses climb to $66.1 million
- Midera Q2 FY26 net earnings drop 62.9% to $11 million; net sales rise 13.2% to $245 million
- Voyager Technologies President Matthew James Kuta sells USD 8.56 million in common shares
- Laird Superfood Q2 revenue crushes estimates, jumping 244% on retail expansion, acquisition contributions
- Heritage Global Q2 adjusted EBITDA misses as specialty lending exit weighs
- BRIEF-Cineverse Q1 Revenue USD 30.595 Million
- Bridgeline Q3 FY26 net loss narrows to $468,000; revenue rises 1.98% to $3.9 million
- Firy Q2 FY26 net loss widens to $24.5 million; revenue rises 23% year over year to $31 million
- Cibus Q2 FY26 net loss narrows 17% to $22.1 million; revenue rises 6.54% to $994,000
- Cineverse 1Q Loss/Shr 28c >CNVS
- CbdMD: Introducing a Zero-Proof Kava Beverage Under Oasis Brand >YCBD
- MacroGenics Q2 FY26 turns to net income of $19.52 million; revenue more than doubled to $32.83 million
- Caribou Biosciences Q2 FY26 GAAP net loss narrows to USD 24.3 million; revenue falls to USD 1.5 million
- PetMeds Q1 FY27 net loss narrows to $6.1 million; net sales fall 19.9% to $41 million
- Pinterest CEO Bill Ready speaks at Goldman Sachs Communacopia + Technology Conference
- Medpace director Cornelius P. McCarthy III sells 1,140 shares for $690,121.80
- Invivyd Q2 FY26 net loss widens to $44.4 million; revenue rises 21% to $14.3 million
- Roadzen Q1 FY27 net loss widens to US $9.8 million; revenue rises 49% to US $16.2 million
- Elutia secures $15 million loan financing from Avenue Capital Group
- SRX Global FY26 Q3 net loss from continuing operations narrows 40% year over year to $4.1 million; net sales rise 27% to $3.4 million
- Carpenter Technology director Ken Giacobbe files initial beneficial ownership statement
- 10x Genomics director John R. Stuelpnagel sells 20,000 shares worth $1.15 million
- SoundThinking GAAP net loss widens 52.24% to $4.8 million in Q2 FY26; revenue drops 8% to $23.9 million
- AMD SVP, GC & Corporate Secretary Ava Hahn disposes of 143 common shares worth $67,889.25
- Arcadia Biosciences Q2 FY26 net loss widens 41% to $6.27 million; revenue slips 1% to $1.44 million
- Martin Marietta Increases Qtrly Cash Div >MLM
- Martin Marietta Raises Qtr Dividend to 84c Vs. 83c >MLM
- MasterBrand EVP, COO Kurt Wanninger sells 50,000 shares for $461,065
- PEDEVCO Q2 FY26 returns to profit with net income USD 17.45 million; revenue rises 15% QoQ to USD 46.11 million
- Afya 2Q26 net income rises 14% to R$ 201.29 million; revenue increases 5.7% to R$ 972.1 million
- Digimarc Q2 FY26 net loss widens to $12.1 million; revenue falls to $7.4 million
- Beeline Q2 FY26 net loss narrows 24% vs. Q1 to $4 million; net revenue rises 57% year-over-year to $2.6 million
- Merlin Q2 FY26 GAAP net loss narrows to $58.4 million; revenue more than doubled to $2.2 million vs Q1 FY26
- StoneCo H1 net income from continuing operations climbs 103.01% to R$ 2.23 billion; revenue rises 4.43% to R$ 7.17 billion
- TechPrecision FY27 Q1 net loss narrows to $0.2 million; revenue rises 23% to $9.1 million
- Workhorse Q2 FY26 net loss widens to $20.2 million; revenue rises to $3.6 million
- 4D Molecular Therapeutics Q2 FY26 net loss widens to $72.94 million; revenue rises to $3.78 million
- Mad Money’s Jim Cramer Says These 6 AI Stocks are Primed to Surge
- Enhanced Q2 FY26 net loss widens to $61.9 million; revenue rises to $17.7 million
- Vuzix Q2 FY26 net loss narrows to $7.7 million; revenue falls 14% to $1.1 million
- Avax One Q2 FY26 net loss widens to USD 35.1 million; revenue more than doubled to USD 2.8 million
- Veritone Q2 2026 net loss narrows to $22.2 million; revenue rises 4.6% to $24.3 million
- AudioEye Sees 3Q Rev $10.85M-$11.05M >AEYE
- Laird Superfood Continues to Expect Consolidated Net Sales in the Range of $138M to $148 M >LSF
- American Public Education Chief Inno & Tech Officer James Kenigsberg disposes of 1,313 shares for $60,036.36
- Mineralys grants new CMO inducement awards for 135,000 stock options, 102,400 RSUs
- MultiSensor AI Q2 FY26 net loss narrows 26% to USD 2.5 million; revenue rises 19% to USD 1.7 million
- BRIEF-TechPrecision Q1 Sales USD 9.1 Million
- Tenon Medical Q2 FY26 net loss widens to $4.1 million; revenue more than doubles to $1.3 million
- Birchtech Q2 FY26 net loss widens to $3 million; revenue rises 15.15% to $3.8 million
- TSS Q2 FY26 net income slips 3.44% to $1.43 million; revenue drops 20% to $35.14 million
- Aflac files initial beneficial ownership statement naming Japan Post Holdings as 10% owner
- Newsmax swings to Q2 FY26 net income of USD 2.9 million; revenue rises 16.5% to USD 54.1 million
- SideChannel announces special shareholder meeting
- Red Rock Resorts COO Kord Nichols disposes of 27,000 shares worth $1.7 million
- Equillium Q2 FY26 net loss narrows to USD 4.7 million; cash slips to USD 57.2 million
- VirTra Q2 FY26 turns to net loss of $261,258; net sales fall 17% to $5.76 million
- Eton Pharmaceuticals 2Q Rev $37.6M >ETON
- Eton Pharmaceuticals 2Q EPS 35c >ETON
- Eton Pharmaceuticals 2Q Net $11.6M >ETON
